Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair

Author(s):
Kortekaas, K.A.; Baan, A. van der; Aarts, L.P.H.J. (0000-0003-3068-7934); Palmen, M.; Cobbaert, C.M. (0000-0003-3565-1404); Verhagen, J.C.M.; Engbers, F.H.M.; Klautz, R.J.M. (0000-0002-6507-3855); Lindeman, J.H.N. (0000-0002-5656-4345)
Published
2014
Publication type
Article / Letter to editor
anaesthetics volatilesevofluranecardiopulmonary bypassimmune responsemyocardial damagereperfusion injury
Date issued
2014-06-30
Language
English
Is part of
British Journal of Anaesthesia (2014), Vol. 112, no. 6, p. 1005-1014
hdl
1887/106618
doi
10.1093/bja/aet588